{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:07:17Z","timestamp":1786748837041,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00280-019-03897-0","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T17:02:45Z","timestamp":1561654965000},"page":"655-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-3527","authenticated-orcid":false,"given":"Mie","family":"Kotake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Kaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Minato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"3897_CR1","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","volume":"115","author":"M Imazio","year":"2007","unstructured":"Imazio M et al (2007) Indicators of poor prognosis of acute pericarditis. Circulation 115:2739\u20132744","journal-title":"Circulation"},{"key":"3897_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jama.1987.03390080078037","volume":"257","author":"OW Press","year":"1987","unstructured":"Press OW, Livingston R (1987) Management of malignant pericardial effusion and tamponade. JAMA 257:1088\u20131092","journal-title":"JAMA"},{"key":"3897_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMra022643","volume":"349","author":"DH Spodick","year":"2003","unstructured":"Spodick DH (2003) Acute cardiac tamponade. N Engl J Med 349:684\u2013890","journal-title":"N Engl J Med"},{"key":"3897_CR4","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1200\/JCO.2005.00.745","volume":"23","author":"HL Gornik","year":"2005","unstructured":"Gornik HL, Gerhard-Herman M, Beckman JA (2005) Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol 23:5211\u20135216","journal-title":"J Clin Oncol"},{"key":"3897_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1510\/icvts.2010.232546","volume":"11","author":"A Apodaca-Cruz","year":"2010","unstructured":"Apodaca-Cruz A et al (2010) Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion. Interact CardioVasc Thorac Surg 11:154\u2013161","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"3897_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.amjcard.2013.05.066","volume":"112","author":"N Patel","year":"2013","unstructured":"Patel N et al (2013) Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol 112:1235\u20131239","journal-title":"Am J Cardiol"},{"key":"3897_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1051-0443(91)72490-1","volume":"2","author":"RA Gatenby","year":"1991","unstructured":"Gatenby RA et al (1991) Percutaneous catheter drainage for malignant pericardial effusion. J Vasc Intervent Radiol 2:151\u2013155","journal-title":"J Vasc Intervent Radiol"},{"key":"3897_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0022-5223(96)70046-6","volume":"112","author":"EA Maher","year":"1996","unstructured":"Maher EA, Shepherd FA, Todd TJ (1996) Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 112:637\u2013643","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3897_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/0002-9149(87)90411-5","volume":"60","author":"FA Shepherd","year":"1987","unstructured":"Shepherd FA et al (1987) Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 60:1161\u20131166","journal-title":"Am J Cardiol"},{"key":"3897_CR10","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1053\/euhj.2002.3328","volume":"23","author":"B Maisch","year":"2002","unstructured":"Maisch B (2002) Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23:1625\u20131631","journal-title":"Eur Heart J"},{"key":"3897_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9149(00)00937-1","volume":"86","author":"TS Bishiniotis","year":"2000","unstructured":"Bishiniotis TS et al (2000) Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol 86:362\u2013364","journal-title":"Am J Cardiol"},{"key":"3897_CR12","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1378\/chest.126.5.1412","volume":"126","author":"A Martinoni","year":"2004","unstructured":"Martinoni A et al (2004) Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest 126:1412\u20131416","journal-title":"Chest"},{"key":"3897_CR13","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1200\/JCO.1998.16.7.2371","volume":"16","author":"M Colleoni","year":"1998","unstructured":"Colleoni M et al (1998) Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol 16:2371\u20132376","journal-title":"J Clin Oncol"},{"key":"3897_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/thx.49.6.594","volume":"49","author":"LN Lee","year":"1994","unstructured":"Lee LN et al (1994) Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. Thorax 49:594\u2013595","journal-title":"Thorax"},{"key":"3897_CR15","doi-asserted-by":"publisher","first-page":"e19687","DOI":"10.1200\/jco.2010.28.15_suppl.e19687","volume":"28","author":"I Moya","year":"2010","unstructured":"Moya I (2010) Efficacy and safety of intrapericardial bleomycin for malignant pericardial effusion. J Clin Oncol 28:e19687","journal-title":"J Clin Oncol"},{"key":"3897_CR16","first-page":"135","volume":"26","author":"E Musch","year":"2003","unstructured":"Musch E et al (2003) Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion. Onkologie 26:135\u2013139","journal-title":"Onkologie"},{"key":"3897_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1179\/joc.1998.10.5.399","volume":"10","author":"J Norum","year":"1998","unstructured":"Norum J, Lunde P, Aasebo U, Himmelmann A (1998) Mitoxantrone in malignant pericardial effusion. J Chemother 10:399\u2013404","journal-title":"J Chemother"},{"key":"3897_CR18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1378\/chest.109.6.1452","volume":"109","author":"I Lashevsky","year":"1996","unstructured":"Lashevsky I et al (1996) Intrapericardial minocycline sclerosis for malignant pericardial effusion. Chest 109:1452\u20131454","journal-title":"Chest"},{"key":"3897_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00000421-199908000-00015","volume":"22","author":"O Kawashima","year":"1999","unstructured":"Kawashima O, Kurihara T, Kamiyoshihara M, Sakata S, Ishikawa S, Morishita Y (1999) Management of malignant pericardial effusion resulting from recurrent cancer with local instillation of aclarubicin hydrochloride. Am J Clin Oncol 22:396\u2013398","journal-title":"Am J Clin Oncol"},{"key":"3897_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2169\/internalmedicine1962.28.62","volume":"28","author":"T Imamura","year":"1989","unstructured":"Imamura T et al (1989) Intrapericardial instillation of OK-432 for the management of malignant pericardial effusion: report of three cases. Jpn J Med 28:62\u201366","journal-title":"Jpn J Med"},{"key":"3897_CR21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1054\/bjoc.2000.1397","volume":"83","author":"T Moriya","year":"2000","unstructured":"Moriya T, Takiguchi Y, Tabeta H, Watanabe R, Kimura H, Nagao K, Kuriyama T (2000) Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer. Br J Cancer 83:858\u2013862","journal-title":"Br J Cancer"},{"key":"3897_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jjco\/hyi019","volume":"35","author":"K Kaira","year":"2005","unstructured":"Kaira K et al (2005) Management of malignant pericardial effusion with instillation of\u00a0mitomycin C\u00a0in non-small cell lung cancer. Jpn J Clin Oncol 35:57\u201360","journal-title":"Jpn J Clin Oncol"},{"key":"3897_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/sj.bjc.6604866","volume":"100","author":"H Kunitoh","year":"2009","unstructured":"Kunitoh H et al (2009) A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br J Cancer 100:464\u2013469","journal-title":"Br J Cancer"},{"key":"3897_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/014107688708000811","volume":"80","author":"PJ Woll","year":"1987","unstructured":"Woll PJ, Knight RK, Rubens RD (1987) Pericardial effusion complicating breast cancer. J R Soc Med 80:490\u2013491","journal-title":"J R Soc Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03897-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03897-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03897-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T23:18:15Z","timestamp":1593127095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03897-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3897"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03897-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}